Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 3/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.73 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | BLM | P54132 | 1/20 | 0.69 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.69 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.69 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.69 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.69 |
| ▸ | TK2 | O00142 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Broxuridine SCHEMBL37420 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL10316347 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL14457631 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL27756 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL9153195 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL27755 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL20769775 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL21137660 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL21423028 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 | |
| Broxuridine SCHEMBL5981680 | 1.00 | TK1 (0.73) | TK1LMNASMN1; SMN2CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 16169 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101943-A1 | ANTI-HUMAN CLAUDIN-18.2 ANTIBODIES FOR IN VITRO DIAGNOSTICS | AGILENT TECHNOLOGIES, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-12612662-B2 | DNA repair site detection for personal genomics, epigenomics, and gene therapy | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2026-04-28 | — | — | US | claimed |
| US-12570704-B2 | Functionally modified maytansinoids and compositions and methods of use thereof | University of Georgie Research Foundation, Inc. (US) | 2026-03-10 | — | — | US | claimed |
| US-20260049142-A1 | ANTI-HUMAN ICOS ANTIBODIES FOR USE IN IMMUNOHISTOCHEMISTRY (IHC) PROTOCOLS AND FOR DIAGNOSING CANCER | AGILENT TECHNOLOGIES, INC. (US) | 2026-02-19 | — | — | US | claimed |
| EP-4687863-A1 | RADIOPROTECTION BY INHIBITION OF SUPEROXIDE DISMUTASE 1 | Deutsches Krebsforschungszentrum (DE) | 2026-02-11 | — | — | EP | claimed |
| EP-4677107-A1 | METHOD FOR NATIVE STRAND SEQUENCING OF ENRICHED GENOMIC REGIONS | Nanohyb, LLC (US) | 2026-01-14 | — | — | EP | claimed |
| US-12473663-B2 | Compositions and methods for immune repertoiresequencing | Life Technologies Corporation (US) | 2025-11-18 | — | — | US | claimed |
| EP-4069255-B1 | IDENTIFYING NON-PRODUCTIVE SPLICE SITES | UNIV MASSACHUSETTS (US) | 2025-10-01 | — | — | EP | claimed |
| US-20250257104-A1 | TARGETED INTRACELLULAR DELIVERY OF LARGE NUCLEIC ACIDS | HOFFMANN-LA ROCHE INC. (US) | 2025-08-14 | — | — | US | claimed |
| EP-3562511-B1 | RNAI THERAPIES FOR CEREBRAL ISCHEMIA | VIVIBABA INC (US) | 2025-08-06 | — | — | EP | claimed |
| EP-0397753-A4 | DETERMINATION OF GENETIC SEX IN RUMINANTS USING Y-CHROMOSOME-SPECIFIC POLYNUCLEOTIDES | — | 1991-06-19 | — | — | EP | claimed |
| US-5023172-A | Forming clonable hybrid multicellular spheroids of feeder cells entrapping tumor cells to provide them with an in vivo environment; evaluation of treatments | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1991-06-11 | — | — | US | claimed |
| WO-1991006674-A1 | METHOD AND DEVICE FOR THE DETECTION OF ANTIBIOTIC RESISTANCE | SCOTGEN LTD. (GB) | 1991-05-16 | — | — | WO | claimed |
| EP-0397753-A1 | DETERMINATION OF GENETIC SEX IN RUMINANTS USING Y-CHROMOSOME-SPECIFIC POLYNUCLEOTIDES. | ADVANCED RIVERINA HOLDINGS (AU) | 1990-11-22 | — | — | EP | claimed |
| EP-0276287-A4 | SEX DETERMINATION IN RUMINANTS USING Y-CHROMOSOME SPECIFIC POLYNUCLEOTIDES. | UNIV AUSTRALIAN (AU) | 1989-09-19 | — | — | EP | claimed |
| WO-1989007154-A1 | DETERMINATION OF GENETIC SEX IN RUMINANTS USING Y-CHROMOSOME-SPECIFIC POLYNUCLEOTIDES | ADVANCED RIVERINA HOLDINGS LIMITED (AU) | 1989-08-10 | — | — | WO | claimed |
| US-4780406-A | Flow cytometric measurement of total DNA and incorporated halodeoxyuridine | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1988-10-25 | — | — | US | claimed |
| EP-0276287-A1 | SEX DETERMINATION IN RUMINANTS USING Y-CHROMOSOME SPECIFIC POLYNUCLEOTIDES. | UNIV AUSTRALIAN (AU) | 1988-08-03 | — | — | EP | claimed |
| WO-1988001300-A1 | SEX DETERMINATION IN RUMINANTS USING Y-CHROMOSOME SPECIFIC POLYNUCLEOTIDES | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1988-02-25 | — | — | WO | claimed |
| US-4585736-A | Flow cytometric measurement of total DNA and incorporated halodeoxyuridine | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1986-04-29 | — | — | US | claimed |